ABCB1 rs4148739: Understanding Your Genetic Variant
The rs4148739 variant is a single nucleotide polymorphism located within the ABCB1 gene. This gene encodes a protein that acts as an efflux pump, and variations here are studied for their potential influence on how the body processes and transports certain medications.
What each genotype means
Typical ABCB1 genotype
This genotype represents the most common genetic configuration for this specific variant in many populations. Research into this variant focuses on its potential role in drug transport across the blood-brain barrier, though clinical evidence remains mixed regarding its impact on individual drug response. Please discuss any concerns regarding medication efficacy or side effects with your healthcare provider or pharmacist.
This is the most frequent genotype observed in most global populations.
Heterozygous variant carrier
You carry one copy of the variant allele, which may influence the activity of the P-glycoprotein drug efflux pump. While some studies suggest this variant could affect how certain medications are transported or metabolized, the clinical significance is not fully established and varies by medication. Always consult your clinician before making changes to your prescribed treatment plan.
This genotype is found in a significant portion of the population, consistent with a global minor allele frequency of approximately 13%.
Homozygous variant carrier
You carry two copies of the variant allele, which may be associated with altered expression or function of the ABCB1 protein. Scientific literature indicates that variations in this gene can influence drug pharmacokinetics, but these effects are often drug-specific and context-dependent. Please consult with your pharmacist or physician to understand if this genotype is relevant to your specific medications.
This genotype is less common than the others, occurring in a smaller percentage of the population based on the reported minor allele frequency.
What is rs4148739?
The rs4148739 variant is a specific genetic change, or single nucleotide polymorphism (SNP), found within the ABCB1 gene. Located on chromosome 7, this variant represents a single position in the DNA sequence where individuals may carry different nucleotides. In the context of genomics, rs4148739 is often studied alongside other nearby variants because it exists within a tight linkage block. This means that rs4148739 is frequently inherited together with other specific SNPs in the same region of the gene. Because these variants are inherited as a group, researchers often look at them collectively to understand how they might influence the function of the ABCB1 gene. While it is a well-documented marker in genetic databases, it is important to remember that a single SNP is rarely the sole determinant of a complex biological trait. Instead, it serves as a piece of the puzzle in understanding the broader genetic landscape of how our bodies interact with various substances.
The Role of the ABCB1 Gene
The ABCB1 gene provides instructions for creating a protein known as P-glycoprotein, or multidrug resistance protein 1. This protein functions as an energy-dependent efflux pump, which is essentially a molecular gatekeeper found in the cell membranes of various tissues, including the liver, kidneys, small intestine, and the blood-brain barrier. Its primary job is to transport a wide variety of molecules, including toxins and many therapeutic drugs, out of cells. By pumping these substances out, P-glycoprotein helps protect sensitive tissues from the accumulation of potentially harmful compounds. Because it is so active in the blood-brain barrier, it plays a critical role in limiting how much of certain medications can enter the brain. When the function of this pump is altered, it can theoretically change the concentration of drugs within the body or the brain, which is why the ABCB1 gene is a major focus in the field of pharmacogenomics.
Research and Clinical Evidence
Research into rs4148739 and other ABCB1 variants has primarily focused on how they might affect drug response. Because P-glycoprotein influences drug concentrations, scientists have investigated whether specific genotypes correlate with better or worse outcomes for patients taking medications like antidepressants or other CNS-active drugs. However, the evidence remains mixed and inconclusive. While some studies have suggested that certain ABCB1 variants might be associated with differences in drug efficacy or side effects, other studies have found no significant clinical impact. For instance, in the treatment of depression, some reports indicate a potential link, while others show no clear correlation. The clinical significance of this variant is currently considered moderate at best, and it is not used as a standard diagnostic tool for prescribing medication. Because of these conflicting results, it is essential to view these findings as statistical associations rather than definitive predictors of how an individual will respond to a specific treatment.
Population Frequency
The rs4148739 variant is a common genetic marker found across diverse human populations. According to data from major genomic catalogs, the Global Minor Allele Frequency (GMAF) for this variant is approximately 0.1318. This frequency indicates that the variant is present in a significant portion of the population, rather than being a rare mutation. Because it is relatively common, it is frequently included in large-scale genetic studies and pharmacogenomic research. While the frequency can vary between different ancestral groups, the overall prevalence suggests that many individuals carry at least one copy of the minor allele. Understanding this frequency helps researchers design better studies and interpret how common these genetic variations are in the general public, though it does not provide information about an individual's specific health status or drug response.
What You Can Do With This Information
If you have received information about your rs4148739 genotype, it is important to understand its limitations. This variant is a subject of ongoing scientific research, not a clinical diagnostic test. It cannot predict with certainty how you will react to any medication, nor can it determine if a drug will be effective for you. Many factors beyond genetics—such as your age, weight, diet, other medications you are taking, and your overall health—play a much larger role in how your body processes drugs. You should never use genetic information to make decisions about starting, stopping, or changing the dosage of any medication. If you are curious about how your genetics might relate to your treatment plan, the best course of action is to discuss this with your clinician or pharmacist. They are trained to interpret medical data in the context of your full health history and can provide guidance based on established clinical guidelines rather than individual genetic markers.
How common is this variant?
The rs4148739 variant is common, with a Global Minor Allele Frequency (GMAF) of approximately 0.1318 across diverse populations.
Frequently asked questions
Does rs4148739 mean I will have drug resistance?
No, having this variant does not mean you have drug resistance. While the ABCB1 gene is involved in drug transport, the clinical impact of this specific SNP is not strong enough to predict how you will respond to medication.
Should I change my medication based on my ABCB1 genotype?
You should never change your medication based on genetic test results. Always consult with your doctor or pharmacist before making any changes to your prescribed treatment plan.
Is rs4148739 a diagnostic test for disease?
No, rs4148739 is not a diagnostic test for any disease. It is a genetic marker studied in the context of pharmacogenomics to understand how genes might influence drug processing.
Why do studies on ABCB1 show different results?
Genetic studies often show mixed results because drug response is complex and influenced by many factors, including environment, lifestyle, and other genes. A single SNP like rs4148739 rarely has a large enough effect to be the sole cause of a clinical outcome.
Sources & further reading
Educational information only, last refreshed 9/27/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs4148739?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ABCB1
This variant in the ABCB1 gene, which encodes the P-glycoprotein transporter, is a well-established marker for drug transport across the blood-brain barrier and drug efflux.
Synonymous variant (c.3435C>T) in ABCB1 linked to altered P-glycoprotein expression and multi-drug transporter pharmacokinetics.
Carriers of the ancestral homozygous genotype (GG) show significantly worse progression-free survival in breast carcinoma patients compared to those with the non-ancestral allele.
A variant associated with potential differences in drug absorption and clinical outcomes in patients undergoing specific pharmacological therapies.
This SNP is linked to variations in the pharmacokinetics of drugs that are substrates for the ABCB1 transporter protein.
Nonsynonymous variant (Ala893Ser/Thr) in ABCB1/MDR1 altering P-glycoprotein transporter kinetics and plasma concentrations of drugs such as digoxin, fexofenadine, and tacrolimus.